期刊文献+

辛伐他汀治疗老年不稳定性心绞痛的临床效果观察 被引量:1

下载PDF
导出
摘要 目的 探讨辛伐他汀对老年不稳定性心绞痛 (UAP)的疗效。方法 将 72例老年UAP随机分为两组 ,常规组 35例 ,给予常规治疗 ;辛伐他汀组 37例 ,在常规治疗上加辛伐他汀 ,疗程 6个月。结果 两组病人心绞痛发作及 ST明显下降 (P<0 0 5或P <0 0 1) ;辛伐他汀组TC、TG及LDL -C明显下降 (P <0 0 5或P <0 0 1) ,HDL -C明显升高 (P <0 0 1) ,CRP明显下降 (P <0 0 5 ) ,发生急性心肌梗死、需PCI或CABG者明显减少 (P <0 0 5 ) ;副作用轻微。结论 辛伐他汀对老年UAP能有效调脂 ,明显减少心脏事件 ,安全。
作者 赖敏
出处 《广西医学》 CAS 2004年第10期1467-1468,共2页 Guangxi Medical Journal
  • 引文网络
  • 相关文献

参考文献5

二级参考文献16

  • 1陈新谦 金有豫.新编药物学,第14版[M].北京:人民卫生出版社,1997.317-318.
  • 2曾群英 张育君.辛伐他汀(舒降之)治疗冠心病高胆固醇血症的临床研究[J].新医学,1998,29(1):11-13.
  • 3[1]Carlson LA, Rosenhamer G. Reduction in mortlity in Stockholm Ischemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand, 1988;223:405~418
  • 4[2]Buchwald H, Matts JP, Fitch LL, et al. for the Program on the Surgical Control of Hyperlipidemias (POSCH)Group: Changes in sequential coranary arteriograms and subsequent coronary events. JAMA,1992;268:1429
  • 5[3]Scandinavian Simvastatin Survival Study(4S) Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease.Lancet, 1994; 344:1383~ 1389
  • 6[4]Sacks FM, Pfeffer MA, Moye LA,et al. for the Cholesterol And Recurrent Events Trial(CARE). The effect of pravastatin on coronaryevents after myocardial infarction in patients with average cholesterol levels. N Engl J Med, 1996; 335:1001~1009
  • 7[5]National Cholesterol Education Program: Second report of the expert on detection, evaluation, and treatment of high blood cholesterol in adult. Circulation, 1994;89:1329
  • 8[6]The Long Term Investigation With Pravastatin In Ischaemic Disease (LIPID)Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998; 339:1349~1357
  • 9[7]Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary disease in men with hypercholesterolemia. West of Scotland Coronary Prevention Study (WOSCOPS) Group. N Engl J Med, 1995; 333:1301~1307
  • 10[8]Down JR, Clearfield M, Weis S, et al. for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA,1998;279:1615~1622

共引文献3281

同被引文献8

引证文献1

二级引证文献2

;
使用帮助 返回顶部